Why Chemours Plunged on Wednesday

Chemours stock fell 18.7% after reporting Q2 earnings that missed revenue expectations and showed a 31% decline in adjusted EPS to $0.42. The decline was driven by lower sales of Optane refrigerants due to channel inventory buildup and the absence of the wound-down SPS Capstone business. While the company's AI-focused data center materials segment is growing, it remains too small to offset declines in larger segments. Management maintains a 1-5% full-year growth forecast, supported by price increases and R&D focus on data centers.